| 000 | 01342 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517155741.0 | ||
| 264 | 0 | _c20181001 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155217710553 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCuellar, Sandra | |
| 245 | 0 | 0 |
_aBCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cSep 2018 |
||
| 300 |
_a433-452 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 700 | 1 | _aVozniak, Michael | |
| 700 | 1 | _aRhodes, Jill | |
| 700 | 1 | _aForcello, Nicholas | |
| 700 | 1 | _aOlszta, Daniel | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 24 _gno. 6 _gp. 433-452 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155217710553 _zAvailable from publisher's website |
| 999 |
_c27245461 _d27245461 |
||